B-Scada, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data B-Scada, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2011	FY2011	FY2012	FY2013	FY2014	FY2015
Revenue	0.82	0.98	1.07	1.55	2.04	1.94
Cost of revenue				0.18	0.25	0.45
Gross profit				1.37	1.79	1.49
Research and development				0.09	0.12	0.12
General and administrative				0.42	0.57	1.02
Operating expenses	1	0.92	0.9	1.07	1.5	2.49
Operating income	-0.18	0.06	0.17	0.48	0.54	-0.56
Interest expense	-0	-0	-0	-0.01	0	0.01
Interest income				0	0	0
Pre-tax income	-0.19	0.04	0.15	0.46	0.54	-0.56
Income tax				-0.41	-0.49	-0.16
Net income	-0.19	0.04	0.15	0.87	1.03	-0.4
EBITDA	-0.17	0.07	0.18	0.48	0.55	-0.54
EPS, basic	-0.01		0.01	0.04	0.04	-0.01
EPS, diluted	-0.01		0.01	0.04	0.04	-0.01
Shares, basic (weighted)		24.6	24.6	24.6	25.3	27.2
Shares, diluted (weighted)		24.6	24.6	24.7	25.3	27.2

Balance sheet

	FY2011	FY2011	FY2012	FY2013	FY2014	FY2015
Cash and equivalents	0.07	0.01	0.09	0.25	1.14	0.84
Receivables	0.07	0.06	0.1	0.12
Inventory						0
Other current assets	0.01	0	0	0.01	0.23	0.03
Total current assets	0.15	0.25	0.35	0.65	2.01	1.18
Property, plant and equipment	0.03	0.02	0.01	0.01	0.22	0.23
Intangible assets				0.11	0.11	0.31
Other non-current assets				0	0
Total assets	0.18	0.27	0.37	1.11	3.06	2.78
Accounts payable	0.13	0.15	0.16	0.2	0.14	0.05
Accrued liabilities						0.16
Deferred revenue	0.17	0.09	0.06	0.11
Short-term debt					0.02	0.02
Total current liabilities	0.45	0.49	0.44	0.31	0.34	0.42
Long-term debt					0.1	0.09
Total liabilities	0.45	0.49	0.44	0.31	0.44	0.51
Total debt					0.12	0.1
Paid-in capital	7.1	7.1	7.1	7.1	7.9	7.97
Retained earnings	-7.37	-7.33	-7.17	-6.3	-5.27	-5.67
Other comprehensive income					-0.01	-0.03
Shareholders' equity	-0.27	-0.22	-0.07	0.8	2.63	2.28
Total equity	-0.27	-0.22	-0.07	0.8	2.63	2.28
Total liabilities and equity	0.18	0.27	0.37	1.11	3.06	2.78
Shares outstanding	24.6	24.6	24.6	24.6	27.2	2.72

Cash flow statement

	FY2011	FY2011	FY2012	FY2013	FY2014	FY2015
Net income	-0.19	0.04	0.15	0.87	1.03	-0.4
Depreciation and amortization	0.01	0.01	0.01	0.01	0.01	0.02
Stock-based compensation	0.07	0				0.07
Deferred income tax			-0.06	-0.58	-0.68	-0.16
Change in receivables	0.06	-0.01	0.05	0.01	0.11	-0.17
Change in inventory						0
Change in payables	0.02	0.02	0.02	-0.03	-0.06	0.07
Cash from operations	0.01	-0.16	0.13	0.42	0.21	-0.05
Capital expenditures	0.01		0.01	-0.01	-0.1	-0.02
Cash from investing	-0.01		-0.01	-0.05	-0.1	-0.22
Debt repaid				-0.08	-0.01	-0.02
Stock issued					0.8
Cash from financing	0.05	0.11	-0.05	-0.21	0.79	-0.02
Net change in cash	0.05	-0.05	0.08	0.16	0.89	-0.3
Free cash flow	0.02		0.14	0.41	0.11	-0.07
Interest paid			0.01	0.06	0	0.01

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to April 30, 2016; growth uses fiscal years. Valuation uses the share price of $0.58 on September 28, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	68.4%	Gross profit / revenue.
Operating margin	-21.1%	Operating income / revenue.
EBITDA margin	-20.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-21.3%	Pre-tax income / revenue.
Net margin	-14.2%	Net income / revenue.
Operating cash flow margin	-30.6%	Cash from operations / revenue.
Return on equity (ROE)	-8.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-7.4%	Net income / average total assets.
Return on invested capital (ROIC)	-15.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	9.3%	Research and development expense / revenue.
Stock-based pay / revenue	2.6%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	1.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-5.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	21.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	18.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-17.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Operating income growth, 1y	-203.3%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-198.0%	EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y	-138.7%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-125.0%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-123.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-160.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-13.2%	Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	-9.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	96.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	72.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	7.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	3.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	4.86x	Current assets / current liabilities.
Quick ratio	3.54x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	3.54x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.03x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	2.9%	Total debt / total assets.
Liabilities / assets	11.7%	Total liabilities / total assets.
Net debt	-$996.4K	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	-68.7x	Operating income / interest expense.
Working capital	$1.2M	Current assets - current liabilities.
Goodwill and intangibles / assets	14.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$2.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.52x	Revenue / average total assets.
Fixed asset turnover	7.96x	Revenue / average property, plant and equipment.
Days payables	76 days	365 x average accounts payable / cost of revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.08	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$0.56	Revenue / diluted weighted shares.
Operating cash flow per share	-$0.17	Cash from operations / diluted weighted shares.
Book value per share	$0.95	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.79	Tangible book value / shares outstanding.
Cash per share	$0.36	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$1.8M	Share price x shares outstanding.
Enterprise value	$778.0K	Market cap + total debt - cash - short-term investments.
P/S	1.03x	Market cap / revenue.
P/B	0.61x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.73x	Market cap / tangible book value, when positive.
EV/Sales	0.45x	Enterprise value / revenue.
Earnings yield	-13.8%	Net income / market cap (the inverse of P/E).

What was B-Scada, Inc.'s revenue in fiscal 2015?

B-Scada, Inc. reported revenue of $1.9M for fiscal 2015, 5% lower than the year before.

Was B-Scada, Inc. profitable in fiscal 2015?

No. It reported a net loss of $398.2K.

How much free cash flow did B-Scada, Inc. generate in fiscal 2015?

Cash from operations of $47.4K minus capital expenditures of $19.3K left free cash flow of -$66.7K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to B-Scada, Inc.